Jennifer Holman, MD
Dermatology · Tyler, TXNPI 1447354626
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $492,285 of the $622,379 with a category attached, or 79.1%. AbbVie accounts for 67.6% of it on its own, with 39 other manufacturers making up the rest. Reporting peaked in 2019 at $156,751 and has fallen 52.8% since, to $73,947 in 2025. Among dermatology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,183 payments — averaging $526.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$421K
- Galderma Laboratories, L.p.$108K
- Lilly USA, LLC$84K
- Johnson & Johnson$3K
- Sanofi$1K
- Regeneron Healthcare Solutions, Inc.$894
- plus $4K from 34 others
Across 24 payments — averaging $11,777 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$283K
What the payments were for
- Consulting fees$22,9884%
- Speaking & faculty fees$492,28579%
- Travel & lodging$84,24414%
- Food & beverage$22,6954%
- Education$1690%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 645 | $420,796 |
| Galderma Laboratories, L.p. | 102 | $108,304 |
| Lilly USA, LLC | 154 | $84,372 |
| Johnson & Johnson | 53 | $2,706 |
| Sanofi | 55 | $1,474 |
| Regeneron Healthcare Solutions, Inc. | 32 | $894 |
| Revance Therapeutics, Inc. | 18 | $770 |
| UCB, Inc. | 19 | $504 |
| Solta Medical, A Division Of Bausch Health US, LLC | 4 | $417 |
| LEO Pharma Inc. | 13 | $331 |
| E.r. Squibb & Sons, L.L.C. | 13 | $312 |
| Sun Pharmaceutical Industries Inc. | 12 | $237 |
| Novartis | 13 | $226 |
| Pfizer | 9 | $207 |
| Organon | 6 | $88 |
| Medtronic | 1 | $77 |
| Incyte Corporation | 3 | $67 |
| Boehringer Ingelheim | 2 | $61 |
| Sanofi-aventis U.S. LLC | 1 | $49 |
| Janssen Scientific Affairs, LLC | 2 | $44 |
| Mayne Pharma Commercial LLC | 2 | $39 |
| Kerecis Limited | 1 | $39 |
| Dermavant Sciences, Inc. | 2 | $33 |
| Almirall LLC | 2 | $33 |
| Sientra, Inc. | 1 | $33 |
| DUSA Pharmaceuticals, Inc. | 2 | $31 |
| Kyowa Kirin, Inc. | 2 | $29 |
| Sandoz | 1 | $21 |
| Strata Skin Sciences, Inc. | 2 | $20 |
| Aclaris Therapeutics, Inc. | 1 | $19 |
| Botanix SB Inc | 1 | $18 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $16 |
| Genentech USA, Inc. | 1 | $15 |
| Smith+Nephew | 1 | $15 |
| Krystal Biotech Inc | 1 | $14 |
| Merz North America, Inc. | 1 | $14 |
| Amgen | 1 | $14 |
| KCI USA, Inc. | 1 | $14 |
| Mission Pharmacal Company | 1 | $13 |
| EPI Health, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$622,379 in reported general payments places this provider in the 95th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 16 | $345,289 |
| Humira(Cf) PenAdalimumab | 11 | $70,362 |
| Clobetasol Propionate | 105 | $4,706 |
| Doxycycline Hyclate | 164 | $3,112 |
| Mupirocin | 280 | $2,336 |
| Ketoconazole | 105 | $1,663 |
| Tacrolimus | 12 | $1,612 |
| Triamcinolone Acetonide | 144 | $1,498 |
| Metronidazole | 27 | $1,297 |
| Minocycline Hcl | 79 | $1,119 |
| Roflumilast | 12 | $1,022 |
| Minoxidil | 104 | $1,007 |
| Fluconazole | 28 | $614 |
| MethotrexateMethotrexate Sodium | 24 | $587 |
| Hydroxychloroquine Sulfate | 15 | $577 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Tyler
- Edward LainAustin$2.5M
- William CragunSan Antonio$2.2M
- Alpesh DesaiHouston$1.6M
- Craig TellerBellaire$1.3M
- Jennifer CatherDallas$1.3M
- Emily BeckerSan Antonio$1.2M
- Ross RaduskyDallas$1.2M
- Joseph MerolaDallas$1.2M
- Daniel CarrascoAustin$1.1M
- Dale SchaeferAustin$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.